Heipram

Heipram is a prescription oral medication that contains the selective serotonin reuptake inhibitor escitalopram as its active ingredient. It is marketed in the European Union and is classified as an antidepressant. The product is intended for oral administration and is available only with a doctor's prescription. Heipram belongs to the drug class of SSRIs and is used under medical supervision for several clinical mood‑related conditions.

Heipram is prescribed for the treatment of several psychiatric disorders that involve mood and anxiety dysregulation.

- Major depressive disorder (MDD) in adults. - Generalized anxiety disorder (GAD) as a first‑line option. - Social anxiety disorder (SAD) to reduce fear of social situations. - Panic disorder, including agoraphobia, to lessen panic attacks. - Adjunctive therapy for patients who have not responded adequately to other antidepressants. - Off‑label use in certain obsessive‑compulsive or stress‑related conditions, when clinically appropriate.

The safety profile of Heipram reflects the typical effects observed with escitalopram therapy.

Common: - Nausea or upset stomach. - Headache. - Insomnia or somnolence. - Dry mouth. - Increased sweating. - Dizziness.

Serious: - Suicidal thoughts or behavior, especially in younger adults. - Serotonin syndrome (e.g., agitation, rapid heart rate, fever). - Severe allergic reaction (e.g., rash, swelling, difficulty breathing).

Healthcare providers consider several precautionary factors before initiating Heipram therapy.

- Assess for a personal or family history of bipolar disorder or mania. - Evaluate risk of suicidal ideation, particularly during the first weeks of treatment. - Use cautiously in patients with hepatic or renal impairment; dose adjustments may be needed. - Discuss potential effects on pregnancy and breastfeeding, as safety data are limited. - Monitor for hyponatremia in elderly patients or those on diuretics. - Avoid abrupt discontinuation to reduce the risk of withdrawal symptoms.

Escitalopram can interact with a range of other medicines; clinicians review concomitant drugs before prescribing Heipram.

Avoid: - Monoamine oxidase inhibitors (MAOIs) and other serotonergic agents (e.g., tramadol, linezolid) due to risk of serotonin syndrome. - Pimozide, as combined use may cause serious cardiac effects. - Certain anti‑platelet or anticoagulant drugs that increase bleeding risk.

Use with caution: - Non‑steroidal anti‑inflammatory drugs (NSAIDs) and aspirin, which may heighten bleeding tendencies. - Other antidepressants or antipsychotics that affect QT interval. - CYP2C19 or CYP3A4 inhibitors/inducers (e.g., fluconazole, carbamazepine) that can alter escitalopram plasma levels.